Ultrasound-based artificial intelligence model for prediction of Ki-67 proliferation index in soft tissue tumors.

Rationale And Objectives: To investigate the value of deep learning (DL) combined with radiomics and clinical and imaging features in predicting the Ki-67 proliferation index of soft tissue tumors (STTs).

Materials And Methods: In this retrospective study, a total of 394 patients with STTs admitted from January 2021 to December 2023 in two separate hospitals were collected. Hospital-1 was the training cohort (323 cases, of which 89 and 234 were high and low Ki-67, respectively) and Hospital-2 was the external validation cohort (71 cases, of which 23 and 48 were high and low Ki-67, respectively). Clinical and ultrasound characteristics including age, sex, tumor size, morphology, margins, internal echoes and blood flow were assessed. Risk factors with significant correlations were screened by univariate and multivariate logistic regression analyses. After extracting the radiomics and DL features, the feature fusion model is constructed by Support Vector Machine. The prediction results obtained from separate clinical features, radiomics features and DL features were combined to construct decision fusion models. Finally, the DeLong test was used to compare whether the AUCs between the models were significantly different.

Results: The three feature fusion models and three decision fusion models constructed demonstrated excellent diagnostic performance in predicting Ki-67 expression levels in STTs. Among them, the feature fusion model based on clinical, radiomics, and DL performed the best with an AUC of 0.911 (95% CI: 0.886-0.935) in the training cohort and 0.923 (95% CI: 0.873-0.972) in the validation cohort, and proved to be well-calibrated and clinically useful. The DeLong test showed that the decision fusion models based on clinical, radiomics and DL performed significantly worse than the three feature fusion models on the validation set. There was no statistical difference in diagnostic performance between the other models.

Conclusion: The ultrasound-based fusion model of clinical, radiomics, and DL features showed good performance in predicting Ki-67 expression levels in STTs.